HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
Description
This grant opportunity aims to enhance HIV/AIDS prevention tools for populations affected by alcohol use, considering both episodic and long-term patterns. It focuses on understanding the behavioral and biological risks of HIV in these groups and seeks research that integrates prevention and treatment strategies. The goal is to reduce new infections by developing, testing, and implementing interventions across diverse settings. Key research areas include PrEP utilization, treatment as preven…
The FOA seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HIV acquisition. This includes integration of effective prevention and treatment interventions with…
Source
Grant ID
PAS-23-173
Agency
National Institutes of Health
Subcategory/Subagency
National Institute on Alcohol Abuse and Alcoholism
Program
SBIR
Key Dates
Opportunity Released
May 12, 2023
Open for Submission
May 12, 2023
Submission Deadline
May 7, 2026
Application Window Closes
May 7, 2026
Similar opportunities
- HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
- Notice of Special Interest (NOSI): Research to Address Ending the HIV Epidemic Initiative Goals Relevant to Substance Using Populations At-Risk for or Living with HIV
National Institutes of Health
- HIV Prevention and Alcohol (R34 Clinical Trials Optional)
National Institutes of Health
- Notice of Funding Opportunity for Research on Interventions for People Who Use Drugs
National Institutes of Health
- Notice of Special Interest (NOSI): Innovative Technologies to develop novel tools to prevent and treat HIV in underserved populations
National Institutes of Health